Document detail

This concept note describes the methods used to assess the prevalence of any HIVDR and HIVDR by PMTCT exposure among children less than 18 months of age using remnant dried blood spot specimens from early infant diagnosis over a 12-month period

Children,  HIV,  hiv drug resistance,  hiv drugs,  ART,  ART drugs,  ARV,  ART therapy,  vertical transmission/PMTCT,  PMTCT,  Surveillance,